From Biomarker Discovery to Clinical Applications of Metabolomics in Glioblastoma

Background/Objectives: In recent years, interest in studying changes in cancer metabolites has resulted in significant advances in the metabolomics field. Glioblastoma remains the most aggressive and lethal brain malignancy, which presents with notable metabolic reprogramming. Methods: We performed...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Neja Šamec, Gloria Krapež, Cene Skubic, Ivana Jovčevska, Alja Videtič Paska
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2025-04-01
Edice:	Metabolites
Témata:	omics metabolome multiomic integration tumor metabolic reprogramming biomarker diagnosis
On-line přístup:	https://www.mdpi.com/2218-1989/15/5/295
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!